Omega Fund Management, LLC
10 holdingsFiling period: 2026-03-31Current AUM: $200.6Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | BCAX | Bicara Therapeutics Inc. | 2.39M | $47.6M | $64.8M | 32.32% | +187.5K | 2026-03-31 |
| 2 | NUVB | Nuvation Bio Inc. | 8.08M | $34.7M | $51.2M | 25.50% | -- | 2026-03-31 |
| 3 | BBOT | BridgeBio Oncology Therapeutics Inc. | 3.29M | $29.4M | $26.6M | 13.27% | -- | 2026-03-31 |
| 4 | — | Kestra Med Technologies Ltd | 1.02M | $20.4M | $20.4M | 10.16% | -351,442 | 2026-03-31 |
| 5 | BBNX | Beta Bionics Inc. | 1.32M | $13.2M | $16.9M | 8.42% | -- | 2026-03-31 |
| 6 | — | enGene Holdings Inc. | 876.4K | $6.0M | $6.0M | 2.97% | -- | 2026-03-31 |
| 7 | ALMS | Alumis Inc. | 241.3K | $5.3M | $6.8M | 3.40% | -411,968 | 2026-03-31 |
| 8 | SANA | Sana Biotechnology, Inc. | 843.8K | $2.4M | $2.6M | 1.32% | -- | 2026-03-31 |
| 9 | IMA | ImageneBio, Inc. | 455.4K | $2.3M | $2.5M | 1.26% | -- | 2026-03-31 |
| 10 | REPL | Replimune Group | 248.7K | $1.9M | $2.8M | 1.39% | -- | 2026-03-31 |
← Scroll →